Effect of obesity on serum prostate-specific antigen in nigerian men

Urologia Internationalis

Volumn 89, Issue 1, 2012, Pages 52-56

  Ikuerowo, S O ^a   Omisanjo, O A ^a   Bioku, M J ^a   Ajala, M O ^b   Esho, J O ^a  

^a LAGOS STATE UNIVERSITY   (Nigeria)

^b Dental Department   (Nigeria)

Author keywords

Body mass index; Obesity; Prostate specific antigen; Waist to hip ratio

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER SCREENING; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGERIA; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; WAIST HIP RATIO;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; DIGITAL RECTAL EXAMINATION; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NIGERIA; OBESITY; ODDS RATIO; PROSTATE-SPECIFIC ANTIGEN; WAIST-HIP RATIO;

EID: 84864588552     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000337171     Document Type: Article

References (38)

1. Ogunbiyi JO, Shittu OB: Increased incidence of prostate cancer in Nigerians. J Natl Med Assoc 1999; 91:159-164.
2. Mohammed AZ, Edino ST, Ochicha O, Gwarzo AK, Samaila AA: Cancer in Nigeria: a 10-year analysis of the Kano cancer registry. Niger J Med 2008; 17:280-284.
3. Ajape AA, Babata A, Abiola OO: Knowledge of prostate cancer screening among native African urban population in Nigeria. Nig Q J Hosp Med 2010; 20: 94-96.
4. Oesterling JE: Age-specific reference ranges for serum PSA. N Engl J Med 1996; 335:345-346.
5. Banez LL, Hamilton RJ, Partin AW, et al: Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007; 298:2275-2280. (Pubitemid 350146217)
6. Grubb RL 3rd, Black A, Izmirlian G, et al: Serum prostate-specific antigen hemodilu-tion among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2009; 18: 748-751.
7. Price MM, Hamilton RJ, Robertson CN, Butts MC, Freedland SJ: Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic. Urology 2008; 71: 787-791.
8. Rundle A, Neugut AI: Obesity and screening PSA levels among men undergoing an an-nua l physica l exam. Prostate 2008; 68: 373-380. (Pubitemid 351342643)
9. Werny DM, Thompson T, Saraiya M, et al: Obesity is negatively associated with prostate-specific antigen in US men, 2001-2004. Cancer Epidemiol Biomarkers Prev 2007; 16: 70-76. (Pubitemid 46174266)
10. Hekal IA, Ibrahiem EI: Obesity-PSA relationship: a new formula. Prostate Cancer Prostatic Dis 2010; 13: 186-190.
11. Kim JM, Song PH, Kim HT, Moon KH: Effect of obesity on prostate-specific antigen, prostate volume, and international prostate symptom score in patients with benign pros-tatic hyperplasia. Korean J Urol 2011; 52:401-405.
12. Quelly SB, Lieberman LS: Global prevalence of overweight and obesity in preschoolers. A nthropol Anz 2011; 68: 437-456.
13. Shayo GA, Mugusi FM: Prevalence of obesity and associated risk factors among adults in Kinondoni municipal district, Dar es Salaam Tanzania. BMC Public Health 2011; 11:365.
14. Muller H, Raum E, Rothenbacher D, Steg-maier C, Brenner H: Association of diabetes and body mass index with levels of prostate-specific antigen: implications for correction of prostate-specific antigen cutoff values? Cancer Epidemiol Biomarkers Prev 2009; 18: 1350-1356.
15. Hutterer G, Perrotte P, Gallina A, et al: Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening. Eur J Cancer 2007; 43:1180-1187. (Pubitemid 46590732)
16. Ku JH, Kim ME, Lee NK, Park YH, Ahn JO: Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men. Urology 2003; 61: 132-136. (Pubitemid 36151728)
17. Capitanio U, Perrotte P, Hutterer GC, et al: Ef fect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1,490 men. Int J Urol 2009; 16: 91-95.
18. Kubota Y, Seike K, Maeda S, Shinohara Y, Iwata M, Sugimoto N: Relationship between prostate-specific antigen and obesity in prostate cancer screening: analysis of a large cohor t in Japa n. Int J Urol 2011; 18: 72-75.
19. Culp S, Porter M: The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men. BJU Int 2009; 104:1457-1461.
20. Carroll P, Coley C, McLeod D, et al: Prostate-specific antigen best practice policy-part II: prostate cancer staging and post-treatment follow-up. Urology 2001; 57: 225-229. (Pubitemid 32140793)
21. Smith RA, Cokkinides V, Eyre HJ: American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 2004; 54:41-52. (Pubitemid 38443419)
22. Ajape AA, Mustapha K, Lawal IO, Mbibu HN: Survey of urologists on clients' demand for screening for prostate cancer in Nigeria. Niger J Clin Pract 2011; 14:151-153.
23. Osegbe DN: Prostate cancer in Nigerians: facts and nonfacts. J Urol 1997; 157: 1340-1343. (Pubitemid 27130810)
24. Badmus TA, Adesunkanmi AR, Yusuf BM, et al: Burden of prostate cancer in southwestern Nigeria. Urology 2010; 76:412-416.
25. Flegal KM, Carroll MD, Ogden CL, Curtin LR: Prevalence and trends in obesity among US adults, 1999-2008. JAM A 2010; 303: 235-241.
26. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625-1638. (Pubitemid 36459468)
27. Rapp K, Schroeder J, Klenk J, et al: Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 2005; 93: 1062-1067. (Pubitemid 41548403)
28. De Nunzio C, Albisinni S, Freedland SJ, et al: Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study. Urol Oncol 2011, E-pub ahead of print.
29. Rohrmann S, Roberts WW, Walsh PC, Platz EA: Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. Prostate 2003; 55:140-146. (Pubitemid 36444001)
30. Gong Z, Neuhouser ML, Goodman PJ, et al: Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2006; 15: 1977-1983. (Pubitemid 44664277)
31. De Nunzio C, Freedland SJ, Miano L, Finazzi Agro E, Banez L, Tubaro A: The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort ana lysis. Eur J Surg Oncol 2011; 37: 1025-1029.
32. Amling CL, Riffenburgh RH, Sun L, et al: Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004; 22:439-445. (Pubitemid 41079772)
33. Freedland SJ, Aronson WJ, Kane CJ, et al: Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 2004; 22: 446-453. (Pubitemid 41079773)
34. Dimitropoulou P, Martin RM, Turner EL, et al: Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study. Br J Cancer 2011; 104:875-881.
35. Pater LE, Hart KW, Blonigen BJ, Lindsell CJ, Barrett WL: Relationship between prostate-specific antigen, age, and body massindex in a prostate cancer screening population. Am J Clin Oncol 2011, E-pub ahead of print.
36. Wright JL, Lin DW, Stanford JL: The effect of demographic and clinical factors on the relationship between BMI and PSA levels. Prostate 2011; 71: 1631-1637.
37. Eastham JA, Sartor O, Richey W, Moparty B, Sullivan J: Racial variation in prostate specific antigen in a large cohort of men without prostate cancer. J La State Med Soc 2001; 153: 184-189.
38. Aoki Y, Arai Y, Maeda H, Okubo K, Shinohara K: Racial differences in cellular composition of benign prostatic hyperplasia. Prostate 2001; 49:243-250. (Pubitemid 33116999)